Cargando…
The efficacy of guided growth as an initial strategy for Blount disease treatment
PURPOSE: The aim of this study was to evaluate the success of guided growth by temporal hemiepiphysiodesis of the lateral proximal tibia as a first line treatment option for Blount disease. METHODS: This was a retrospective multicentre study conducted in five centres, covering data on 55 limbs in 45...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Editorial Society of Bone & Joint Surgery
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453169/ https://www.ncbi.nlm.nih.gov/pubmed/32874365 http://dx.doi.org/10.1302/1863-2548.14.200070 |
_version_ | 1783575304510373888 |
---|---|
author | Danino, Barry Rödl, Robert Herzenberg, John E. Shabtai, Lior Grill, Franz Narayanan, Unni Gigi, Roy Segev, Eitan Wientroub, Shlomo |
author_facet | Danino, Barry Rödl, Robert Herzenberg, John E. Shabtai, Lior Grill, Franz Narayanan, Unni Gigi, Roy Segev, Eitan Wientroub, Shlomo |
author_sort | Danino, Barry |
collection | PubMed |
description | PURPOSE: The aim of this study was to evaluate the success of guided growth by temporal hemiepiphysiodesis of the lateral proximal tibia as a first line treatment option for Blount disease. METHODS: This was a retrospective multicentre study conducted in five centres, covering data on 55 limbs in 45 patients, with an average follow-up of 24.5 months following plate insertion. Preoperative alignment analysis was compared with three measurements taken postoperatively. The normalization of the mechanical medial proximal tibia angle (mMPTA) was defined as the primary outcome measure. RESULTS: Mean age at surgery was 9.5 years. Average preoperative mMPTA was 77°. On average, at 24.5 months post-surgery, mMPTA was 86.33°, while 43/55 limbs (78.18%) have achieved normalization (mMPTA 85° to 90°). Average rate of correction was 1° per month. When grouping the children as infantile (11 limbs), juvenile (12 limbs) and adolescent (32 limbs), operated on before the age of four years, between four and ten years and after the age of ten years, respectively, 63.63%, 66.67%, 87.5% have completed correction of deformity during the follow-up period. Interestingly, the femoral component of the deformity has achieved correction as well in 33/55 limbs (64%). CONCLUSION: Hemiepiphysiodesis is an effective first line treatment for Blount disease. Overall success rate is good but varies according to child’s age. Adolescent Blount has the best chance of achieving full correction while same treatment is less effective in infantile Blount. Level of evidence: IV |
format | Online Article Text |
id | pubmed-7453169 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The British Editorial Society of Bone & Joint Surgery |
record_format | MEDLINE/PubMed |
spelling | pubmed-74531692020-08-31 The efficacy of guided growth as an initial strategy for Blount disease treatment Danino, Barry Rödl, Robert Herzenberg, John E. Shabtai, Lior Grill, Franz Narayanan, Unni Gigi, Roy Segev, Eitan Wientroub, Shlomo J Child Orthop Original Clinical Article PURPOSE: The aim of this study was to evaluate the success of guided growth by temporal hemiepiphysiodesis of the lateral proximal tibia as a first line treatment option for Blount disease. METHODS: This was a retrospective multicentre study conducted in five centres, covering data on 55 limbs in 45 patients, with an average follow-up of 24.5 months following plate insertion. Preoperative alignment analysis was compared with three measurements taken postoperatively. The normalization of the mechanical medial proximal tibia angle (mMPTA) was defined as the primary outcome measure. RESULTS: Mean age at surgery was 9.5 years. Average preoperative mMPTA was 77°. On average, at 24.5 months post-surgery, mMPTA was 86.33°, while 43/55 limbs (78.18%) have achieved normalization (mMPTA 85° to 90°). Average rate of correction was 1° per month. When grouping the children as infantile (11 limbs), juvenile (12 limbs) and adolescent (32 limbs), operated on before the age of four years, between four and ten years and after the age of ten years, respectively, 63.63%, 66.67%, 87.5% have completed correction of deformity during the follow-up period. Interestingly, the femoral component of the deformity has achieved correction as well in 33/55 limbs (64%). CONCLUSION: Hemiepiphysiodesis is an effective first line treatment for Blount disease. Overall success rate is good but varies according to child’s age. Adolescent Blount has the best chance of achieving full correction while same treatment is less effective in infantile Blount. Level of evidence: IV The British Editorial Society of Bone & Joint Surgery 2020-08-01 /pmc/articles/PMC7453169/ /pubmed/32874365 http://dx.doi.org/10.1302/1863-2548.14.200070 Text en Copyright © 2020, The author(s) http://creativecommons.org/licenses/by-nc/4.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution-Non Commercial 4.0 International (CC BY-NC 4.0) licence (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed. |
spellingShingle | Original Clinical Article Danino, Barry Rödl, Robert Herzenberg, John E. Shabtai, Lior Grill, Franz Narayanan, Unni Gigi, Roy Segev, Eitan Wientroub, Shlomo The efficacy of guided growth as an initial strategy for Blount disease treatment |
title | The efficacy of guided growth as an initial strategy for Blount disease treatment |
title_full | The efficacy of guided growth as an initial strategy for Blount disease treatment |
title_fullStr | The efficacy of guided growth as an initial strategy for Blount disease treatment |
title_full_unstemmed | The efficacy of guided growth as an initial strategy for Blount disease treatment |
title_short | The efficacy of guided growth as an initial strategy for Blount disease treatment |
title_sort | efficacy of guided growth as an initial strategy for blount disease treatment |
topic | Original Clinical Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453169/ https://www.ncbi.nlm.nih.gov/pubmed/32874365 http://dx.doi.org/10.1302/1863-2548.14.200070 |
work_keys_str_mv | AT daninobarry theefficacyofguidedgrowthasaninitialstrategyforblountdiseasetreatment AT rodlrobert theefficacyofguidedgrowthasaninitialstrategyforblountdiseasetreatment AT herzenbergjohne theefficacyofguidedgrowthasaninitialstrategyforblountdiseasetreatment AT shabtailior theefficacyofguidedgrowthasaninitialstrategyforblountdiseasetreatment AT grillfranz theefficacyofguidedgrowthasaninitialstrategyforblountdiseasetreatment AT narayananunni theefficacyofguidedgrowthasaninitialstrategyforblountdiseasetreatment AT gigiroy theefficacyofguidedgrowthasaninitialstrategyforblountdiseasetreatment AT segeveitan theefficacyofguidedgrowthasaninitialstrategyforblountdiseasetreatment AT wientroubshlomo theefficacyofguidedgrowthasaninitialstrategyforblountdiseasetreatment AT daninobarry efficacyofguidedgrowthasaninitialstrategyforblountdiseasetreatment AT rodlrobert efficacyofguidedgrowthasaninitialstrategyforblountdiseasetreatment AT herzenbergjohne efficacyofguidedgrowthasaninitialstrategyforblountdiseasetreatment AT shabtailior efficacyofguidedgrowthasaninitialstrategyforblountdiseasetreatment AT grillfranz efficacyofguidedgrowthasaninitialstrategyforblountdiseasetreatment AT narayananunni efficacyofguidedgrowthasaninitialstrategyforblountdiseasetreatment AT gigiroy efficacyofguidedgrowthasaninitialstrategyforblountdiseasetreatment AT segeveitan efficacyofguidedgrowthasaninitialstrategyforblountdiseasetreatment AT wientroubshlomo efficacyofguidedgrowthasaninitialstrategyforblountdiseasetreatment |